High-grade Ta/ T1 Papillary Disease Bladder Cancer
2 clinical trials · Condition
◉ Watch High-grade Ta/ T1 Papillary Disease Bladder Cancer
| Record | Firm | Date |
|---|---|---|
| Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin (NCT04452591) | CG Oncology, Inc. | 2020-10-27 |
Track High-grade Ta/ T1 Papillary Disease Bladder Cancer automatically
Every clearance here is in the API, with alerts when new ones post.